Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neuroblastoma × Temozolomide × Clear all

Phase

Phase 2 14 Phase 1 12 Phase 1/2 9 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 35 Brain Neoplasms 15 Astrocytoma 15 Central Nervous System Neoplasms 9 Oligodendroglioma 8 Gliosarcoma 8 Melanoma 6 Glioma 6 Recurrence 4 Neoplasms 3 Neoplasm Metastasis 2 Diffuse Intrinsic Pontine Glioma 2 Choroid Plexus Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Sarcoma, Ewing 1 Sarcoma 1 Rhabdoid Tumor 1 Rare Diseases 1 Optic Nerve Glioma 1 Neurotoxicity Syndromes 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Neuroepithelial 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms, Connective Tissue 1 Neoplasms, Bone Tissue 1 Neoplasms by Histologic Type 1 Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms 1 Lymphoma, Follicular 1

Interventions

Cyclophosphamide 17 Carboplatin 13 Etoposide 11 Doxorubicin 11 Vincristine 9 Filgrastim 9 Cisplatin 9 Radiotherapy 7 Melphalan 7 Topotecan 6 Isotretinoin 6 Granulocyte Colony-Stimulating Factor 6 Peripheral Blood Stem Cell Transplantation 5 sargramostim 4 etoposide phosphate 4 dinutuximab 3 Neoadjuvant Therapy 3 Magnetic Resonance Spectroscopy 3 Colony-Stimulating Factors 3 Busulfan 3 3-Iodobenzylguanidine 3 fluorodopa F 18 2 aldesleukin 2 Watchful Waiting 2 Vindesine 2 Thiotepa 2 Platinum 2 Observation 2 Ifosfamide 2 Chemotherapy, Adjuvant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07375563 2026-01-29

NB-NK-2026

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡